STOCK TITAN

CANNABIX TECHS INC ORD - $BLOZF STOCK NEWS

Welcome to our dedicated page for CANNABIX TECHS ORD news (Ticker: $BLOZF), a resource for investors and traders seeking the latest updates and insights on CANNABIX TECHS ORD stock.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect CANNABIX TECHS ORD's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of CANNABIX TECHS ORD's position in the market.

Rhea-AI Summary

Cannabix Technologies Inc. is collaborating with Breathalyser Sales & Service Pty in Australia to distribute its new Breath Logix Alcohol screening device. This device offers features like pre-calibrated cartridge technology, automatic BAC level detection, and real-time alerts for users in various sectors. Cannabix aims to provide an innovative solution for alcohol screening in workplaces and other settings.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
24.09%
Tags
none
-
Rhea-AI Summary
Cannabix Technologies Inc. reports the deployment of its Breath Logix Alcohol Breathalyzer device by Friedel, in Montana, USA, under the 24/7 Sobriety Program. The device has been used for daily alcohol testing, collecting over a thousand breath samples autonomously, saving time and money for the clinic. The program aims to reduce re-arrests of DUI offenders through daily breath testing, with the Breath Logix offering significant process efficiency and cost savings. The device features patent-pending pre-calibrated cartridge technology, contactless and straw test modes, and real-time alert notifications for precise BAC levels.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
35.4%
Tags
none
-
Rhea-AI Summary
Cannabix Technologies Inc. will be presenting its marijuana breathalyzer technology at the International Association for Chemical Testing (IACT) conference. The presentation will cover the science and technology behind cannabis breath testing, aiming to enhance public safety for law enforcement and workplace environments. Dr. Bruce Goldberger, a renowned expert in forensic medicine, will lead the workshop session discussing the pharmacokinetics and pharmacodynamics of cannabinoids in breath, collection devices, laboratory workflows, and analytical considerations.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
28.7%
Tags
conferences
Rhea-AI Summary
Cannabix Technologies begins certification of contactless alcohol breathalyzer and rebrands product series to Breath Logix. The company ships its Industrial Series Contactless Alcohol Breathalyzers for certification testing, introducing new features and technology to improve workplace alcohol testing.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
8.21%
Tags
none
-
Rhea-AI Summary
Cannabix Technologies Inc. announces Dr. Phillip Olla joining the board of directors, bringing expertise in breath technologies and healthcare innovation. The company also reports the cancellation of 1.5 million stock options and the granting of 2.7 million incentive stock options to directors and consultants.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.6%
Tags
management
-
Rhea-AI Summary
Cannabix Technologies Inc. successfully analyzed breath samples from a green lab testing day in Maryland at a third-party location for the first time. The data showed quantified delta9-THC from smoking and edibles consumption, marking a critical step in reproducibility of Cannabix hardware and analysis methods. The Company's breath collection unit and laboratory breath sampler are being used to provide a new method for drug detection that complements gold-standard mass spectrometry and significantly simplifies laboratory analysis methods.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.18%
Tags
none
Rhea-AI Summary
Cannabix Technologies Inc. (CSE: BLO) (OTC PINK: BLOZF) has filed a provisional patent application for its Mass Spectrometer Breath Sampler technology, allowing for the rapid and efficient analysis of low volatility analytes like delta-9 THC in human breath samples. The company's innovative hardware device simplifies laboratory analysis methods and provides consistent results in detecting THC from smoking and edibles up to 4 hours after consumption.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
12.14%
Tags
none
-
Rhea-AI Summary
Cannabix Technologies Inc. (CSE: BLO) (OTC PINK: BLOZF) announces participation in 'green lab' testing day in Montgomery County, Maryland to showcase its marijuana breathalyzer technology.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-11.81%
Tags
conferences
-
Rhea-AI Summary
Cannabix Technologies Inc. has completed preliminary third-party testing on its Contactless Alcohol Breathalyzer (CAB) wall-mounted device, nearing completion of its first commercial version. The CAB workplace series is being prepared for international alcohol standards testing, with a new product name and branding in the works. The device is designed to address workplace safety concerns related to alcohol and marijuana use, offering a targeted solution for employers and organizations.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.49%
Tags
none
Rhea-AI Summary
Cannabix Technologies reports successful quantification of delta-9 THC levels in breath using its MSBS technology. Achieved limit of detection and quantification in the low picogram range. Potential wide-ranging benefits for law enforcement, government, and industry. Re-classification of marijuana as a lower-risk substance may increase demand for THC testing technology.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
4.88%
Tags
none
CANNABIX TECHS INC ORD

OTC:BLOZF

BLOZF Rankings

BLOZF Stock Data

21.94M
104.55M
8.62%
0.01%
Gold Ore Mining
Mining, Quarrying, and Oil and Gas Extraction
Link
United States of America
Burnaby